Krystal Biotech, Inc. (KRYS)
266.90
-7.69
(-2.80%)
USD |
NASDAQ |
Feb 24, 16:00
266.90
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Research and Development Expense (Quarterly) : 13.23M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 23.74M |
| DexCom, Inc. | 148.20M |
| Alkermes Plc | 80.34M |
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Alnylam Pharmaceuticals, Inc. | 372.22M |